findmyKOL

Farhan Raza

Basic profile

University of Wisconsin–Madison

ORCIDNPI
RegionMadison, WI · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Farhan Raza is a Cardiology physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 115 publications with 749 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
115publications

Distinct works indexed by OpenAlex, matched via ORCID.

749citations

Total citations across indexed works.

15h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    60.6%
    Aldosterone antagonist (MRA)11.4%
    Spironolactone100%
    Part D65 patients
    Beta blocker9.6%
    Metoprolol Succinate74%Carvedilol26%
    Part D37 patients

    + 12 more classes in this area

  • Metabolism & gastrointestinal

    19.9%
    SGLT2 inhibitor15.7%
    Jardiance62%Farxiga38%
    Part D43 patients
    Proton pump inhibitor2.2%
    Pantoprazole Sodium68%Omeprazole32%
    Part D<11 patients

    + 2 more classes in this area

  • Blood & clotting

    6.3%
    Factor Xa inhibitor2.5%
    Eliquis100%
    Part D<11 patients
    Prostacyclin Receptor Agonist1.6%
    Uptravi100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)82.6% facility · 17.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”